Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Quick facts
Marketed products
- Vabomere · Other
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: